OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out VRTX/  DE000MB927P6  /

Stuttgart
24/01/2025  18:36:23 Chg.+0.41 Bid19:08:42 Ask19:08:42 Underlying Strike price Expiration date Option type
20.68EUR +2.02% 20.73
Bid Size: 2,000		 20.80
Ask Size: 2,000		 Vertex Pharmaceutica... 223.3404 USD 31/12/2078 Call
GlobeNewswire 13/08/2024 Entrada Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire 09/08/2024 ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 07/08/2024 Editas Medicine Announces Second Quarter 2024 Results and Business Updates
GlobeNewswire 05/08/2024 Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
GlobeNewswire 05/08/2024 CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Newsfile Corp 17/07/2024 Analysts Hunt for Undervalued Biotech Stocks
Newsfile Corp 11/07/2024 Biopharma Stocks Transformative Innovation for the Future of Health
GlobeNewswire 09/07/2024 Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management
GlobeNewswire 09/07/2024 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire 28/06/2024 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire 10/06/2024 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire 29/05/2024 CRISPR Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 23/05/2024 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 15/05/2024 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 09/05/2024 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire 08/05/2024 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 08/05/2024 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire 08/05/2024 Editas Medicine Announces First Quarter 2024 Results and Business Updates
GlobeNewswire 07/05/2024 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 30/04/2024 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire 27/04/2024 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire 25/04/2024 American Kidney Fund Launches National Kidney Health Equity Media Campaign
GlobeNewswire 22/04/2024 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 22/04/2024 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire 22/04/2024 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN